At the end of the latest market close, ENDRA Life Sciences Inc. (NDRA) was valued at $0.90. In that particular session, Stock kicked-off at the price of $0.924 while reaching the peak value of $1.05 and lowest value recorded on the day was $0.9136. The stock current value is $1.05.
Recently in News on January 8, 2021, ENDRA Life Sciences to Present at H.C. Wainwright Virtual BioConnect 2021 Conference. ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that Chairman and CEO Francois Michelon will present at the H.C. Wainwright Virtual BioConnect 2021 Conference being held January 11-14, 2021. The presentation can be accessed here and on the Investor Relations section of the ENDRA website beginning on January 11, 2021 at 6:00 a.m. Eastern time and will be archived for 90 days. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
ENDRA Life Sciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.0500 on 01/12/21, with the lowest value was $0.7600 for the same time period, recorded on 01/04/21.
ENDRA Life Sciences Inc. (NDRA) full year performance was -37.87%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ENDRA Life Sciences Inc. shares are logging -49.71% during the 52-week period from high price, and 75.29% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.60 and $2.09.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3324670 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ENDRA Life Sciences Inc. (NDRA) recorded performance in the market was 40.00%, having the revenues showcasing 44.15% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 34.12M, as it employees total of 15 workers.
The Analysts eye on ENDRA Life Sciences Inc. (NDRA)
During the last month, 0 analysts gave the ENDRA Life Sciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7823, with a change in the price was noted +0.1500. In a similar fashion, ENDRA Life Sciences Inc. posted a movement of +16.67% for the period of last 100 days, recording 381,983 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NDRA is recording 0.09 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.09.
Technical rundown of ENDRA Life Sciences Inc. (NDRA)
Raw Stochastic average of ENDRA Life Sciences Inc. in the period of last 50 days is set at 100.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 100.00%. In the last 20 days, the company’s Stochastic %K was 89.19% and its Stochastic %D was recorded 82.07%.
Considering, the past performance of ENDRA Life Sciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 40.00%. Additionally, trading for the stock in the period of the last six months notably improved by 17.87%, alongside a downfall of -37.87% for the period of the last 12 months. The shares increased approximately by 17.98% in the 7-day charts and went down by 23.53% in the period of the last 30 days. Common stock shares were driven by 44.15% during last recorded quarter.